At present, most of the research is based on animal models and in vitro experiments, and a few pharmacological effects have been clinically confirmed, especially the hypoglycemic effect of catalpol has been verified in the endocrine field, catalpol tablets have entered the phase 2 clinical study (CTR20220555) in China, aiming at evaluating the pharmacokinetics, efficacy and safety of catalpol tablets in patients with type 2 diabetes, small molecular monomer drugs have begun to face the clinic with suitable dosage forms
Aliquoting into sterile, low-bind tubes for storage and use
Bioregulator peptides: organ-specific immune support The bioregulator peptide concept, pioneered by Khavinson and colleagues in Russia, involves short peptides (typically 2-4 amino acids) that target specific organs and tissues
Research Application: AHK-Cu is of primary interest for its effects on fibroblasts, cells that are responsible for the growth and maintenance of extracellular matrix (the stuff between cells)